Natasha Kulviwat, a rising high school senior, discovered a protein that may serve as predictor for suicide and could potentially lead to new strategies for intervention and prevention.
Researchers at Columbia University have found new evidence of how certain transport proteins are working at the molecular level, paving the way for new drugs to treat psychiatric disorders.
A clinical trial conducted by Columbia University and Duke University suggest that donepezil may not improve cognitive performance in people at risk for Alzheimer’s disease who also had depression.
Survivors of opioid overdose are at great risk of dying in the year after overdose, but the deaths are not always caused by drug use, a new study reveals.
Dr. John Mann said this study used much more sophisticated statistical techniques than previous studies to rule out an association between lithium in groundwater and lower risk of bipolar disorder.
Dr. Alan Brown said that "the recognition that environmental factors in early development, prenatal factors, are likely to be very important in schizophrenia and just as important as genes,” is key.
Dr. Ilana Nossel is the medical director and co-associate director of OnTrackNY and an assistant professor of clinical psychiatry at Columbia University Irving Medical Center (CUIMC).
Researchers at Columbia University Irving Medical Center (CUIMC) identified a specific receptor related to the neurotransmitter serotonin that could be targeted with drugs to boost memory.
Cognitive remediation can feasibly be implemented in large systems of care, according to researchers at the New York State Psychiatric Institute and Columbia University Irving Medical Center.
A new study suggests that when a specific approach to supported employment (Individual Placement and Support) is implemented well it is associated with higher employment rates sustained over time.